Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Quotient Diagnostics (Acquired) (AIM: EKF) is Profiled in this Database

Updated At 28 Nov, 2012

Start Free 7 Day Trial Now
Partial description of this company
A1c diabetes testing at the point of care, with results in under 4 minutes

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Quotient Diagnostics (Acquired) (AIM: EKF) plus 4970 other startups.

Start Free 7 Day Trial Now

Learn More About Quotient Diagnostics (Acquired) (AIM: EKF)

Technology/product details

More

Start Free 7 Day Trial Now

Our Clients

1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.jpg
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png